市場調查報告書

C反應性蛋白質(CRP)檢驗市場

C-reactive Protein Testing

出版商 Global Industry Analysts, Inc. 商品編碼 938843
出版日期 內容資訊 英文 199 Pages
商品交期: 最快1-2個工作天內
價格
C反應性蛋白質(CRP)檢驗市場 C-reactive Protein Testing
出版日期: 2020年07月01日內容資訊: 英文 199 Pages
簡介

全球C反應性蛋白質(CRP)檢驗市場在預測期間內預計將以1.4%的年複合成長率增長,達到1億6,440萬美元的規模。

本報告提供全球C反應性蛋白質(CRP)檢驗市場的相關調查,提供市場佔有率,趨勢和成長要素,新型冠狀病毒感染疾病的影響,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

本報告刊載的企業資料:Abaxis, Inc.·Abbott Laboratories·Danaher Corporation·F. Hoffmann-La Roche AG·Laboratory Corporation of America Holdings (LabCorp)·Merck KgaA·Quest Diagnostics, Inc.·Randox Laboratories Ltd.·Siemens Healthineers·Thermo Fisher Scientific, Inc.

目錄

簡介,調查手法,調查範圍

摘要整理

第1章 市場概要

  • 全球競爭市場佔有率
  • 全球競爭市場佔有率方案
  • 新型冠狀病毒感染疾病的影響,全球景氣衰退

第2章 焦點企業

第3章 市場趨勢及成長要素

第4章 全球市場預測

市場分析

  • 各地區市場分析
  • 美國
    • 市場現狀·要點
    • 市場佔有率:各企業
    • 市場分析
  • 加拿大
  • 歐洲
    • 市場現狀·要點
    • 競爭的市場佔有率方案
    • 市場分析
  • 南美
  • 亞太地區
  • 中東
  • 非洲

競爭

  • 企業簡介
目錄
Product Code: MCP11362

Global C-reactive Protein Testing Market to Reach US$1.8 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for C-reactive Protein Testing estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 1.4% over the analysis period 2020-2027.Cardiovascular Diseases, one of the segments analyzed in the report, is projected to grow at a 1.8% CAGR to reach US$531.7 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cancer segment is readjusted to a revised 1% CAGR for the next 7-year period. This segment currently accounts for a 19.9% share of the global C-reactive Protein Testing market.

The U.S. Accounts for Over 29.4% of Global Market Size in 2020, While China is Forecast to Grow at a 1.1% CAGR for the Period of 2020-2027

The C-reactive Protein Testing market in the U.S. is estimated at US$466 Million in the year 2020. The country currently accounts for a 29.38% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$308.6 Million in the year 2027 trailing a CAGR of 1.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 0.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR while Rest of European market (as defined in the study) will reach US$308.6 Million by the year 2027.

Rheumatoid Arthritis Segment Corners a 13.4% Share in 2020

In the global Rheumatoid Arthritis segment, USA, Canada, Japan, China and Europe will drive the 1.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$170.1 Million in the year 2020 will reach a projected size of US$191.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$196.1 Million by the year 2027.We bring years of research experience to this 8th edition of our report. The 199-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abaxis, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Merck KgaA
  • Quest Diagnostics, Inc.
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • C-reactive Protein Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: C-reactive Protein Testing Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: C-reactive Protein Testing Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
  • TABLE 3: C-reactive Protein Testing Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Cardiovascular Diseases (Disease Type) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 5: Cardiovascular Diseases (Disease Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 6: Cardiovascular Diseases (Disease Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Cancer (Disease Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 8: Cancer (Disease Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 9: Cancer (Disease Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Rheumatoid Arthritis (Disease Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 11: Rheumatoid Arthritis (Disease Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
  • TABLE 12: Rheumatoid Arthritis (Disease Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Inflammatory Bowel Disease (Disease Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 14: Inflammatory Bowel Disease (Disease Type) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 15: Inflammatory Bowel Disease (Disease Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Endometriosis (Disease Type) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 17: Endometriosis (Disease Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 18: Endometriosis (Disease Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Lupus (Disease Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027
  • TABLE 20: Lupus (Disease Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 21: Lupus (Disease Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 22: Other Disease Types (Disease Type) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2020 to 2027
  • TABLE 23: Other Disease Types (Disease Type) Global Historic Demand in US$ Thousand by Region/Country: 2012 to 2019
  • TABLE 24: Other Disease Types (Disease Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Clinics (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
  • TABLE 26: Clinics (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019
  • TABLE 27: Clinics (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
  • TABLE 28: Hospitals (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 29: Hospitals (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 30: Hospitals (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 31: Laboratories (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 32: Laboratories (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 33: Laboratories (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 34: Assisted Living Healthcare Facilities (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 35: Assisted Living Healthcare Facilities (End-Use) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 36: Assisted Living Healthcare Facilities (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 37: Home (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
  • TABLE 38: Home (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019
  • TABLE 39: Home (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 40: Other End-Uses (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
  • TABLE 41: Other End-Uses (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 42: Other End-Uses (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US C-reactive Protein Testing Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 43: United States C-reactive Protein Testing Market Estimates and Projections in US$ Thousand by Disease Type: 2020 to 2027
    • TABLE 44: C-reactive Protein Testing Market in the United States by Disease Type: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 45: United States C-reactive Protein Testing Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
    • TABLE 46: United States C-reactive Protein Testing Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 47: C-reactive Protein Testing Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019
    • TABLE 48: C-reactive Protein Testing Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 49: Canadian C-reactive Protein Testing Market Estimates and Forecasts in US$ Thousand by Disease Type: 2020 to 2027
    • TABLE 50: Canadian C-reactive Protein Testing Historic Market Review by Disease Type in US$ Thousand: 2012-2019
    • TABLE 51: C-reactive Protein Testing Market in Canada: Percentage Share Breakdown of Sales by Disease Type for 2012, 2020, and 2027
    • TABLE 52: Canadian C-reactive Protein Testing Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 53: C-reactive Protein Testing Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
    • TABLE 54: Canadian C-reactive Protein Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 55: Japanese Market for C-reactive Protein Testing: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2020-2027
    • TABLE 56: C-reactive Protein Testing Market in Japan: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2012-2019
    • TABLE 57: Japanese C-reactive Protein Testing Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
    • TABLE 58: Japanese Demand Estimates and Forecasts for C-reactive Protein Testing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 59: Japanese C-reactive Protein Testing Market in US$ Thousand by End-Use: 2012-2019
    • TABLE 60: C-reactive Protein Testing Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 61: Chinese C-reactive Protein Testing Market Growth Prospects in US$ Thousand by Disease Type for the Period 2020-2027
    • TABLE 62: C-reactive Protein Testing Historic Market Analysis in China in US$ Thousand by Disease Type: 2012-2019
    • TABLE 63: Chinese C-reactive Protein Testing Market by Disease Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 64: Chinese Demand for C-reactive Protein Testing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 65: C-reactive Protein Testing Market Review in China in US$ Thousand by End-Use: 2012-2019
    • TABLE 66: Chinese C-reactive Protein Testing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European C-reactive Protein Testing Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 67: European C-reactive Protein Testing Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
    • TABLE 68: C-reactive Protein Testing Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 69: European C-reactive Protein Testing Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 70: European C-reactive Protein Testing Market Estimates and Forecasts in US$ Thousand by Disease Type: 2020-2027
    • TABLE 71: C-reactive Protein Testing Market in Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2012-2019
    • TABLE 72: European C-reactive Protein Testing Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
    • TABLE 73: European C-reactive Protein Testing Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 74: C-reactive Protein Testing Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
    • TABLE 75: European C-reactive Protein Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 76: C-reactive Protein Testing Market in France by Disease Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 77: French C-reactive Protein Testing Historic Market Scenario in US$ Thousand by Disease Type: 2012-2019
    • TABLE 78: French C-reactive Protein Testing Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
    • TABLE 79: C-reactive Protein Testing Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
    • TABLE 80: French C-reactive Protein Testing Historic Market Review in US$ Thousand by End-Use: 2012-2019
    • TABLE 81: French C-reactive Protein Testing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 82: C-reactive Protein Testing Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Disease Type for the Period 2020-2027
    • TABLE 83: German C-reactive Protein Testing Historic Market Analysis in US$ Thousand by Disease Type: 2012-2019
    • TABLE 84: German C-reactive Protein Testing Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
    • TABLE 85: C-reactive Protein Testing Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
    • TABLE 86: German C-reactive Protein Testing Market in Retrospect in US$ Thousand by End-Use: 2012-2019
    • TABLE 87: C-reactive Protein Testing Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 88: Italian C-reactive Protein Testing Market Growth Prospects in US$ Thousand by Disease Type for the Period 2020-2027
    • TABLE 89: C-reactive Protein Testing Historic Market Analysis in Italy in US$ Thousand by Disease Type: 2012-2019
    • TABLE 90: Italian C-reactive Protein Testing Market by Disease Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 91: Italian Demand for C-reactive Protein Testing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 92: C-reactive Protein Testing Market Review in Italy in US$ Thousand by End-Use: 2012-2019
    • TABLE 93: Italian C-reactive Protein Testing Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 94: United Kingdom Market for C-reactive Protein Testing: Annual Sales Estimates and Projections in US$ Thousand by Disease Type for the Period 2020-2027
    • TABLE 95: C-reactive Protein Testing Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Disease Type for the Period 2012-2019
    • TABLE 96: United Kingdom C-reactive Protein Testing Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
    • TABLE 97: United Kingdom Demand Estimates and Forecasts for C-reactive Protein Testing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 98: United Kingdom C-reactive Protein Testing Market in US$ Thousand by End-Use: 2012-2019
    • TABLE 99: C-reactive Protein Testing Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 100: Rest of Europe C-reactive Protein Testing Market Estimates and Forecasts in US$ Thousand by Disease Type: 2020-2027
    • TABLE 101: C-reactive Protein Testing Market in Rest of Europe in US$ Thousand by Disease Type: A Historic Review for the Period 2012-2019
    • TABLE 102: Rest of Europe C-reactive Protein Testing Market Share Breakdown by Disease Type: 2012 VS 2020 VS 2027
    • TABLE 103: Rest of Europe C-reactive Protein Testing Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 104: C-reactive Protein Testing Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
    • TABLE 105: Rest of Europe C-reactive Protein Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 106: C-reactive Protein Testing Market in Asia-Pacific by Disease Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 107: Asia-Pacific C-reactive Protein Testing Historic Market Scenario in US$ Thousand by Disease Type: 2012-2019
    • TABLE 108: Asia-Pacific C-reactive Protein Testing Market Share Analysis by Disease Type: 2012 VS 2020 VS 2027
    • TABLE 109: C-reactive Protein Testing Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
    • TABLE 110: Asia-Pacific C-reactive Protein Testing Historic Market Review in US$ Thousand by End-Use: 2012-2019
    • TABLE 111: Asia-Pacific C-reactive Protein Testing Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • REST OF WORLD
    • TABLE 112: Rest of World C-reactive Protein Testing Market Estimates and Forecasts in US$ Thousand by Disease Type: 2020 to 2027
    • TABLE 113: Rest of World C-reactive Protein Testing Historic Market Review by Disease Type in US$ Thousand: 2012-2019
    • TABLE 114: C-reactive Protein Testing Market in Rest of World: Percentage Share Breakdown of Sales by Disease Type for 2012, 2020, and 2027
    • TABLE 115: Rest of World C-reactive Protein Testing Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 116: C-reactive Protein Testing Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
    • TABLE 117: Rest of World C-reactive Protein Testing Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 43